title: Haemophilus influenzae neonatal sepsis--what is appropriate initial therapy?
authors.affiliation: Department of Neonatology, Shaare Zedek Medical Center, Jerusalem, Israel.
authors.forename: M A
authors.initials: MA
authors.lastname: Wilschanski
authors.forename: M S
authors.initials: MS
authors.lastname: Schimmel
authors.forename: M
authors.initials: M
authors.lastname: Isacsohn
authors.forename: A I
authors.initials: AI
authors.lastname: Eidelman
mesh_terms: D000328:Adult; D000667:Ampicillin / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005260:Female; D006192:Haemophilus Infections / Q000188:drug therapy*; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D018805:Sepsis / Q000188:drug therapy*
chemical_list: D002511:Cephalosporins; D000667:Ampicillin